Estimated survival in patients with pulmonary arterial hypertension or CTEPH is worse if they also have atrial arrhythmias, a U.S. study reports.
Read About How Courtagen Introduces New Tests for Mitochrondrial Disorders.
The National Institute for Health and Care Excellence (NICE) in the United Kingdom has recommended Gazyvaro, developed by Roche, for first-line treatment of follicular lymphoma.
Two research projects have been funded by nonprofit Coalition to Cure Calpain 3 to develop gene therapies for limb-girdle muscular dystrophy type 2A.
GenSight has completed patient enrollment ahead of schedule for its ongoing Phase 3 trial assessing the safety and efficacy of GS010 in patients with LHON.
Columnist Radiant Racheli discusses the concept of post-traumatic growth as a positive aftereffect of cancer trauma, and shares the role it's played in her recovery experience.
Lymphoma is a cancer that starts in the white blood cells This article looks at the two main types: Hodgkin lymphoma and non-Hodgkin lymphoma, as well as diagnosis and treatment.
A new study shows that, at least for patients with non-Hodgkin's lymphoma, age should not be a limiting factor for stem cell transplant eligibility.
Pliant has successfully completed a study of its investigational treatment PLN-74809 for IPF, supporting further clinical development.
Columnist Nicola Whitehill shares about the importance of medical research and ways to raise awareness by using social media.
Boating, dating, kayaking, a concert, a Florida safari, meeting a celebrity ... Columnist Radiant Racheli shares the highlights of her efforts to maintain a fun lifestyle while battling lymphoma.
Columnist Sherri Woodbridge shares about the hope and strength she draws from her Christian faith and encourages others to find their own supports to lean on.
A telomerase-based gene therapy for pulmonary fibrosis does not increase the risk of cancer, despite some concerns, a mouse study shows.
Verastem is seeking approval of duvelisib for the treatment of relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in the U.S.
Read about the results from a Phase 4 trial showing that a combo therapy of Ofev and Esbriet is tolerated by most IPF patients.
Read about two Northwestern scientists winning Hartwell Research Awards, one to develop nano-medicines to treat Crohn's disease in children.
The Scleroderma Foundation has named Lesley Ann Saketkoo, a Tulane rheumatologist, as Doctor of the Year for her commited battle against scleroderma.
Read about long-term trials showing that treatment with Ingrezza provides stable amelioration of tardive dyskinesia with high patient satisfaction.
Lymphoma is a cancer that starts in the white blood cells This article looks at the two main types: Hodgkin lymphoma and non-Hodgkin lymphoma, as well as diagnosis and treatment.
Read about the University of Virginia’s Pulmonary Hypertension Center receiving Pulmonary Hypertension Association accreditation.
Read about U.S. research centers now recruiting participants for Phase 3 trial of Alkermes’ drug candidate ALKS 8700 versus Tecfidera to treat RRMS.
Parkinson's patients in the US are being recruited for a new clinical trial that will test the safety of nilotinib, an FDA-approved leukemia treatment, and also its potential efficacy in people with early, moderate and advanced disease.
Columnist Charlene Marshall shares her greatest fears as a young woman living with idiopathic pulmonary fibrosis (IPF).
Read about the newest Innovator Award winners, sharing a total $2.6 million in grants from The Kenneth Rainin Foundation for cutting-edge research into IBD.
According to the John Hopkins Scleroderma Center, one of scleroderma's early symptoms is Raynaud’s phenomenon.
Read about a report that a drug approved to treat non-Hodgkin lymphoma and multiple myeloma, AMD3100, showed promise in treating a mouse model of ALS.
Inventiva's lanifibranor showed no signficant difference from placebo in alleviating skin fibrosis in a Phase 2b study with systemic sclerosis patients.
